01 11Onglyza
02 6Onglyza/Kombiglyze XR/Komboglyze
03 1Onglyza/Kombiglyze XR/Komboglyze
04 1Onglyza/Kombiglyze Xr/Komboglyze
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 470
2019 Revenue in Millions : 527
Growth (%) : -11
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 470
2019 Revenue in Millions : 527
Growth (%) : -11
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 65
2019 Revenue in Millions : 70
Growth (%) : -7
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 360
2020 Revenue in Millions : 470
Growth (%) : -23
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 360
2020 Revenue in Millions : 470
Growth (%) : -23
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 52
2020 Revenue in Millions : 65
Growth (%) : -10
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 257
2021 Revenue in Millions : 360
Growth (%) : -29
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 257
2021 Revenue in Millions : 360
Growth (%) : -29
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 39
2021 Revenue in Millions : 52
Growth (%) : -25
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 29
2022 Revenue in Millions : 39
Growth (%) : -17
LOOKING FOR A SUPPLIER?